Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

Hyponatremia Clinical Trial

Official title:

Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01879774
• Other study ID #: 002
• Status: Completed
• Phase: N/A
• Start date: June 2012
• Est. completion date: April 2022

Study information

• Verified date: May 2022
• Source: University of Cologne
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this epidemiological study is to characterize the neuropsychological and motoric performance in patients with hyponatremia. Newer studies revealed an association between mild hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the paradigm of an "asymptomatic" hyponatremia. Until now, there is no known detailed investigation and characterisation of the cognitive and motoric performance or limitation by this disorder. Therefore this study will investigate patients with hyponatremia on the basis of neuropsychological and neurological tests.

Description:

Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized patients. The prevalence of hospital-associated hyponatremia is estimated to be up to 40%. Especially mild to moderate hyponatremia (125-136 mmo/l) without apparent symptoms has seldomly been accurately assessed but rather seen as clinically irrelevant. Cognitive limitations, unstable gait and motoric disorders as well as depressive conditions were described in smaller studies and single case reports.

In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic hyponatremia it is necessary to establish an accurate phenotyping of patients with hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.

Patients with hyponatremia will be examined on the basis of standardized neuropsychological and neurological tests. Following questions are to be answered with this study:

1. Which cognitive, motoric and psychological functions are impaired due to hyponatremia?

2. Is there a correlation between the extend of hyponatremia and the different test results?

3. Is there an intraindividual difference in test results during hyponatremia and normal sodium concentrations?

In addition to clinical testing, functional magnetic resonance imaging (fMRI) will be performed before and after therapy in up to 40 patients with hyponatremia. Functional magnetic resonance imaging (fMRI) is an imaging procedure in which local changes in cerebral oxygen concentration can be used to draw conclusions about brain activity. In connection with the current research project, an initial contribution is to be made in order to close the existing knowledge gap as to whether a functionally-image-morphologically tangible change in cerebral activity can also be depicted non-invasively by means of fMRI during hyponatremia or after its compensation. Another component of cerebral evaluation in this context is volumetry in fMRI.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 189
• Est. completion date: April 2022
• Est. primary completion date: January 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Men and women 18 years of age or older

• Hyponatremia with serum sodium < 130 mmol/l

• Men and women with normal serum sodium > 130 mmol/l (control group)

Exclusion Criteria:

• traumatic cerebral injury, hemorrhagic and ischemic insult as cause of hyponatremia

• professional or private relationship between subject and the investigators, or dependance on the investigators

• Placement in an institution based on official orders

• Patients who are unable to give informed consent

• Patients with contraindication for MRI investigation

Related Conditions & MeSH terms

• Hyponatremia

Intervention

Other:
• Neuropsychological and motoric tests
Neuropsychological tests Mini Mental Status Test Dem-Tect Rey-Osterrieth Complex Figure Test Trailmaking Test Beck Depression Inventory d2-R (optional) Motoric tests modified UPDRS (Unified Parkinson Disease Rating Scale) Part III Timed-up-and-go Test Halstead Fingertapping Test AIMS (Abnormal involuntary movement scale) EEG (only in patients with hyponatremia) MRI (only in patients with hyponatremia)

Locations

Country	Name	City	State
Germany	University of Cologne	Cologne
Italy	Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio	Firenze
Spain	Hospital Universitario Clinico San Carlos	Madrid

Sponsors (1)

Lead Sponsor	Collaborator
University of Cologne

Countries where clinical trial is conducted

Germany,  Italy,  Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of Performance in individual tests		Change in individual tests at Baseline and at least 48 hours after first assessment
Secondary	Assessment of cerebral basal activity in fMRI during hyponatremia and after its compensation		Change in fMRI from baseline and at least 48 hours after first assessment